IKZF1 and chronic myelogenous leukemia, BCR-ABL1 positive: In this study, we checked the therapeutic efficacy of the complex on CML cells by targeting the BCR-ABL and Notch signaling pathways (Notch-1, 2, and 4) and the Ikaros protein.